About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(PML-RARA)556Kog
transgene insertion 556, Scott Kogan
MGI:3033300
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Pmltm1.1Ews/Pmltm1.1Ews
Tg(PML-RARA)556Kog/0
FVB.Cg-Pmltm1.1Ews Tg(PML-RARA)556Kog MGI:6195067
tg2
Tg(PML-RARA)556Kog/0 FVB/N-Tg(PML-RARA)556Kog MGI:6195072
tg3
Tg(PML-RARA)556Kog/? involves: FVB/N MGI:3815135


Genotype
MGI:6195067
cx1
Allelic
Composition
Pmltm1.1Ews/Pmltm1.1Ews
Tg(PML-RARA)556Kog/0
Genetic
Background
FVB.Cg-Pmltm1.1Ews Tg(PML-RARA)556Kog
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pmltm1.1Ews mutation (0 available); any Pml mutation (91 available)
Tg(PML-RARA)556Kog mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• primary MEFs show a defect in nonhomologous end-joining (NHEJ)

hematopoietic system
• leukemia is characterized by hyperleukocytosis

homeostasis/metabolism
• primary MEFs show a defect in nonhomologous end-joining (NHEJ)

immune system
• leukemia is characterized by hyperleukocytosis

neoplasm
• mice develop acute promyelocytic leukemia spontaneously with a frequency of 13.8% at 18 months of age
• leukemias are characterized by hyperleukocytosis, anemia, and thrombocytosis

growth/size/body

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
acute promyelocytic leukemia DOID:0060318 OMIM:612376
J:262172




Genotype
MGI:6195072
tg2
Allelic
Composition
Tg(PML-RARA)556Kog/0
Genetic
Background
FVB/N-Tg(PML-RARA)556Kog
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• leukemia is characterized by hyperleukocytosis

immune system
• leukemia is characterized by hyperleukocytosis

neoplasm
• mice develop acute promyelocytic leukemia spontaneously with a frequency of 6.8% at 18 months of age
• leukemias are characterized by hyperleukocytosis, anemia, and thrombocytosis

growth/size/body




Genotype
MGI:3815135
tg3
Allelic
Composition
Tg(PML-RARA)556Kog/?
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• epidermal papillomatosis
• mutants develop acute promyelocytic leukemia between 3 and 9 months of age, with a median age of 174 days
• mixed hematopoiesis of normal bone marrow is completely replaced by leukemic cells, splenic and lymphatic architecture is effaced and leukemia extends throughout the hepatic parenchyma
• both preleukemic state and the leukemia can be transplanted to wild-type mice and the preleukemia progresses to acute promyelocytic leukemia

immune system
• impaired neutrophil maturation early in life

hematopoietic system
• impaired neutrophil maturation early in life

cardiovascular system
• some leukemic mutants hemorrhage spontaneously

homeostasis/metabolism
• leukemic mutants are abnormally susceptible to bleeding after injections
• some mutants exhibit fibrin thrombi in pulmonary blood vessels but not in other organs

integument
• epidermal papillomatosis

cellular
• impaired neutrophil maturation early in life

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
acute promyelocytic leukemia DOID:0060318 OMIM:612376
J:39327





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory